申请人:Stadtmueller Heinz
公开号:US20130029993A1
公开(公告)日:2013-01-31
The present invention encompasses compounds of general formula (I)
wherein the groups R
2
to R
6
, A, X, Y and m are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain compounds of this kind and their use as medicaments.
本发明涵盖了一般式(I)的化合物,
其中R2至R6、A、X、Y和m的定义如权利要求书中所述,
这些化合物适用于治疗以细胞过度或异常增殖为特征的疾病,包括含有此类化合物的药物制剂以及它们作为药物的用途。